Helicobacter
is a spiral shaped gram-negative bacteria, causing chronic
inflammation and infection in stomach and duodenum leading to
ulceration. H. pylori is found in 50-80% of patients with gastric
ulcers and in 90% of patients with duodenal ulcers. An estimated one
in six individuals infected with H. pylori are expected to eventually
develop peptic ulcer disease. Infected individuals experience long
asymptomatic conditions with nearly 70% of individuals having minimal
symptoms such as belching, bloating, nausea, vomiting, abdominal
discomfort as occasional, whereas, major symptoms includes abdominal
pain, peptic ulcer, bad breath etc. Helicobacter infection can be
diagnosed by invasive that requires gastric mucosa samples, which are
obtained through endoscopy and used for biopsy or non-invasive tests
that requires blood or stool samples. Invasive tests include
immunoassay, rapid urease test, and histology whereas non-invasive
includes stool antigen assays serology tests and urea breath test.
The
global Helicobacter pylori diagnostics market size was valued at US$
437.3 million in 2017 and is expected to witness a CAGR of 7.1% over
the forecast period (2018 – 2026).
Get
In-Depth Sample Copy of Research @
https://www.coherentmarketinsights.com/insight/request-sample/1874
Increasing
prevalence of helicobacter pylori in emerging economies is propelling
the Helicobacter pylori diagnostics market growth
Prevalence
of helicobacter pylori is declining in developed countries, whereas
its prevalence in emerging economies is increasing. For instance,
according to the Faculty of Medicine of The Chinese University of
Hong Kong (CUHK), 2017, around 4.4 billion people worldwide are
infected with Helicobacter pylori (H. pylori). Furthermore, same
source suggested that prevalence in Africa is up to 80%, which is the
highest globally, while in Asia, over 50% of the population was
infected with H. pylori. Moreover, according to the International
Agency for Research on Cancer report 2014, in 2012, around 952,000
new gastric cancer cases occurred globally and around 734,000 gastric
cancers were estimated to occur due to H. pylori infection. Such high
prevalence of Helicobacter pylori in Africa and Asia is expected to
fuel the regional helicobacter market growth.
Africa
market to exhibit fastest growth over the forecast period
Regionally,
Helicobacter pylori diagnostics market is segmented into - North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa
by Coherent Market Insights. North America Helicobacter pylori
diagnostic market holds dominant position in the global market and
this is attributed to initiatives to provide test kits at low costs
to eradicate H. pylori infection. For instance, antibody-based
detection tests are available at lower cost for enhancing the
eradication of helicobacter pylori infection in Quebec. Moreover,
Agence d’évaluation des technologies et des modes d’intervention
en santé (AETMIS), an independent body reporting to the Quebec
Minister of Health and Social Services, recommends the 13C-urea
breath test to be made available in all areas of Québec. However,
Africa Helicobacter pylori diagnostic market is expected to exhibit
high CAGR, owing to high prevalence of Helicobacter pylori. According
to studies published in Gastroenterology Journal, 2017, the data
suggested that Africa has highest prevalence of H. pylori infection,
which is around 79%.
Inorganic
strategies by key players is fuelling growth of the Helicobacter
pylori diagnostics market
Key
players involved in the global Helicobacter pylori diagnostics market
include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc.,
Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche
Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc.,
Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc.,
and Halyard Health, Inc.
Detailed
Segmentation:
Global
Helicobacter Pylori Diagnostics Market, By Test Type:
-
Invasive
-
Immunoassay
-
Rapid Urease Test
-
Histology
-
Non-invasive
-
Stool Antigen Assays
-
Serology Tests
-
Urea Breath Test
Global
Helicobacter Pylori Diagnostics Market, By End User:
-
Hospitals
-
Clinics
-
Diagnostic Laboratories
-
Others
Global
Helicobacter Pylori Diagnostics Market, By Region:
-
North America
-
Latin America
-
Europe
-
Asia Pacific
-
Middle East
-
Africa
Else
place an Inquire before Purchase “Global Helicobacter Pylori
Diagnostics Market Size, Status and Forecast 2026":
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1874
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment